James Mitchell
Director of Heartland BioVentures
and Director of Investments

Jim Mitchell received his Ph.D. in biochemistry from Iowa State University in 1979. During his subsequent 28-year industrial career, he held R&D and operations positions in six different companies, including his most recent position as vice president for pharmaceutical R&D at Hospira, Inc.

Dr. Mitchell holds several patents in drug delivery and protein chemistry and has been directly involved with the successful development and launch of more than 50 proprietary and generic products. He serves on several advisory boards and has worked at the state level to foster the funding of innovative research across a broad range of technology-based products.

His multi-company R&D and management experience, ranging from drug discovery through commercialization, provides a unique prospective related to the balance between innovation, resource utilization, and R&D cycle times in achieving sustained earnings growth.